Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias (original) (raw)

Oncogene volume 14, pages 1259–1268 (1997)Cite this article

Abstract

Two ets family members, namely erg and Fli-1 are fused with two EWS familiy members namely EWS and TLS/FUS as a result of chromosome translocation in human solid tumors and leukemias. EWS-erg and EWS-Fli-1, which are involved in greater than 95% of Ewing family of tumors, were shown to function as transcriptional activators. TLS/FUS-erg, which is involved in human myeloid leukemias also functions as a transcriptional activator. Expression of these fusion proteins (EWS-erg and EWS-Fli-1) are shown to be essential for maintaining the oncogenic and tumorigenic properties of tumor cells. Cancer is thought to be caused not only by uncontrolled cell proliferation but also by deregulation of programmed cell death. Therefore, we have studied the role of normal (Fli-1 and erg) and aberrant fusion proteins (EWS-erg, EWS-Fli-1 and TLS/FUS-erg) in apoptosis. We have found that expression of normal (Fli-1 and erg) and aberrant fusion proteins inhibit the apoptosis of NIH3T3 cells induced by either serum deprivation or by treatment with calcium ionophore. We have also observed similar suppression of apoptosis in Ewing's sarcoma cells expressing EWS-Fli-1 and EWS-erg proteins suggesting that these fusionproteins may be responsible for the decreased ability of these tumor cells to undergo apoptosis. Inhibition of the expression of these aberrant fusion proteins by antisense RNA technique resulted in increased susceptibility to apoptosis leading to the death of tumor cells. Therefore, our results suggest that one can use therapeutic agents which can down regulate the expression of fusion proteins in combination with chemotherapeutic agents as an effective treatment for these human solid tumors and leukemias.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 50 print issues and online access

$259.00 per year

only $5.18 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Division of Cancer Genetics, Department of Human Genetics, Allegheny University of the Health Sciences, M.S. 481, Broad and Vine Streets, Philadelphia, 19102, Pennsylvania, USA
    Ho-keun Yi, Yasuo Fujimura, Momaru Ouchida, D D K Prasad, Veena N Rao & E Shyam P Reddy
  2. Department of Microbiology and Immunology, Jefferson Medical College, Kimmel Cancer Institute, 233 South 10th Street, Philadelphia, 19107-5541, Pennsylvania, USA
    Ho-keun Yi, Yasuo Fujimura, Veena N Rao & E Shyam P Reddy

Authors

  1. Ho-keun Yi
    You can also search for this author inPubMed Google Scholar
  2. Yasuo Fujimura
    You can also search for this author inPubMed Google Scholar
  3. Momaru Ouchida
    You can also search for this author inPubMed Google Scholar
  4. D D K Prasad
    You can also search for this author inPubMed Google Scholar
  5. Veena N Rao
    You can also search for this author inPubMed Google Scholar
  6. E Shyam P Reddy
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Yi, Hk., Fujimura, Y., Ouchida, M. et al. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.Oncogene 14, 1259–1268 (1997). https://doi.org/10.1038/sj.onc.1201099

Download citation

Keywords

This article is cited by